Skip to content

Monark Criticare: India’s critical care Clindamycin Injection IP 4 ml

GMP conditionsBatch released
Clinark-600, Clindamycin Injection IP 4 ml, manufactured by Monark CriticareClick to enlarge
Anti-Infective

Clinark-600

Clindamycin Injection IP 4 ml

Packing1*4 ml
PresentationInjection
  • Released against specification
  • Certificate of analysis enclosed
  • Injection presentation
  • Pan-India dispatch
Product priceMRP, inclusive of all taxes
₹258
  • 300 injectables
  • 11 therapeutic groups
  • One distributor per district

Uses of Clinark-600

A lincosamide, active against Gram positive cocci and anaerobes, and useful where a beta lactam cannot be used. It penetrates bone and abscess cavities well.

It also suppresses bacterial toxin production, which is why it appears in regimens for necrotising soft tissue infection and toxic shock alongside a cell wall active agent rather than instead of one.

  • Anaerobic infection, including intra abdominal and pelvic sepsis
  • Skin and soft tissue infection, including necrotising infection as part of a regimen
  • Bone and joint infection
  • Serious Gram positive infection in penicillin allergic patients

Indication categories, not an exhaustive list, and not a recommendation for any individual patient.

Quality-driven manufacturing behind Clinark-600

96
Injectables in the live range
11
Therapeutic groups covered
4
Dosage forms manufactured
1
Distributor per district
Territory

PCD pharma franchise for Clinark-600, available across India

Enquiries accepted from every state and union territory. Whether a specific district is still open changes week to week, so it is answered by a person rather than by this page.

North8
  • Punjab
  • Haryana
  • Himachal Pradesh
  • Jammu & Kashmir
  • Uttarakhand
  • Delhi NCR
  • Rajasthan
  • Uttar Pradesh
West & Central5
  • Gujarat
  • Maharashtra
  • Goa
  • Madhya Pradesh
  • Chhattisgarh
South6
  • Karnataka
  • Kerala
  • Tamil Nadu
  • Andhra Pradesh
  • Telangana
  • Puducherry
East & North-East12
  • Bihar
  • Jharkhand
  • Odisha
  • West Bengal
  • Assam
  • Meghalaya
  • Tripura
  • Manipur
  • Nagaland
  • Mizoram
  • Arunachal Pradesh
  • Sikkim

Exclusive district rights — one distributor per district, named in the agreement.

Check my district
The comparison

Why Monark Criticare versus a typical supplier?

Every row is a term stated elsewhere on this site and held to in writing. Nothing here is a claim about a certificate we have not seen.

Factor
Monark Criticare
Typical supplier
Territory
One distributor per district, named in the agreement
Shared, rarely written down
Rate list
Net rates, pack sizes and MRP issued up front
On request, after commitment
First orders
No minimum on the first two order cycles
High minimum from the start
Batch paperwork
Certificate of analysis travels in the consignment
Emailed later, if chased
Manufacturing
GMP conditions, every batch released against specification
Varies by site
Range depth
96 injectables across 11 therapeutic groups
Thin outside the fast movers
Dispatch
Pan-India from one site, cold chain where the molecule needs it
Multi-site, variable
Reply time
Usually inside one working day
Days, or not at all
Territory
Monark CriticareOne distributor per district, named in the agreement
Typical supplierShared, rarely written down
Rate list
Monark CriticareNet rates, pack sizes and MRP issued up front
Typical supplierOn request, after commitment
First orders
Monark CriticareNo minimum on the first two order cycles
Typical supplierHigh minimum from the start
Batch paperwork
Monark CriticareCertificate of analysis travels in the consignment
Typical supplierEmailed later, if chased
Manufacturing
Monark CriticareGMP conditions, every batch released against specification
Typical supplierVaries by site
Range depth
Monark Criticare96 injectables across 11 therapeutic groups
Typical supplierThin outside the fast movers
Dispatch
Monark CriticarePan-India from one site, cold chain where the molecule needs it
Typical supplierMulti-site, variable
Reply time
Monark CriticareUsually inside one working day
Typical supplierDays, or not at all

Start your critical care business with Clinark-600 take the district before it is allocated

Send the districts you cover and the segments you already sell into. You get the rate list, the pack sizes and a straight answer on availability, usually inside one working day.

Get franchise quote

Get franchise quote for Clinark-600

Interested in Clindamycin Injection IP 4 ml for your pharma franchise business? Fill the form and we come back with the rate list, the pack sizes and district availability.

  • Exclusive district rights, recorded in the agreement
  • Net rates, pack sizes and MRP issued before you commit
  • No minimum on the first two order cycles
  • Batch documentation and certificate of analysis with every consignment

Send enquiry

Fill in your details and we will contact you shortly.

Clinark-600  |  Clindamycin Injection IP 4 ml

This website is a business to business platform intended for pharmaceutical traders, distributors, wholesalers, hospitals and healthcare professionals. Product compositions, therapeutic categories and portfolio information are published for commercial and educational reference only.

Nothing here is medical advice, a prescribing recommendation or a substitute for professional diagnosis or treatment. We do not sell medicines directly to individuals, and all trade enquiries are subject to verification of a valid drug licence before any supply is agreed.

The details you send are used to answer this enquiry and to contact you about it, by phone, WhatsApp or email. They are not sold and not passed to anyone outside this company.

Read the full privacy policy

Tick the box above to enable this button

Or call us: +91 90567 60548 | +91 98886 56719

Related products

View all products →